Stay Ahead in Fast-Growing Economies.
Browse Reports Now
Acute Ischemic Stroke (AIS) Market Share, Trends & Market Forecast (2024-2032)
AIS is a stroke that is characterized by restricted blood flow to the brain due to the blood clot blocking or narrowing of the blood vessels that supply blood to the brain.
IMR Group
Description
Acute Ischemic Stroke (AIS) Market Synopsis:
Acute Ischemic Stroke (AIS) Market Size Was Valued at USD 9.24 Billion in 2023, and is Projected to Reach USD 13.73 Billion by 2032, Growing at a CAGR of 4.50% From 2024-2032.
AIS is a stroke that is characterized by restricted blood flow to the brain due to the blood clot blocking or narrowing of the blood vessels that supply blood to the brain. This is a medical hazard, a condition that must be attended to practically immediately in order to reduce the amount of damage that occurs to the brain. Ischaemic strokes make up the largest share of all stroke cases, and the treatment for AIS embraces medications, neurosurgery, and endovascular procedures targeting vessel recanalization and prevention of long-term neurologic deficits.
Some main factors influencing the Acute Ischemic Stroke (AIS) market include the high incidence of stroke across the world due to factors such as high blood pressure, diabetes, smoking and other related factor and the growing geriatric population. AIS is recognized more often as the global elderly population increases; thus, the need to develop efficient treatment methods grows. Also, increased knowledge of AIS and its predictors is compelling people to seek preventive and treatment options earlier, this has cultivated market growth.
There are medical advancements that are also pushing the market higher; some of them include: technological advancements of stroke treatments like the minimally invasive surgical devices. In this study we will also focus on endovascular procedures such as thrombectomy that have significantly improved AIS management in terms of recovery and complications compared to open surgical interventions. Market growth is being fuelled by these innovations, increasing healthcare capabilities and diagnostics enhancing the AIS treatment path.
Acute Ischemic Stroke (AIS) Market Trend Analysis:
Increased Use of Thrombolytics and Antithrombotic Agents
Therapies are rapidly shifting to minimally invasive approaches and, specifically endovascular measures like thrombectomy owing to faster recovery rates and fewer complications. These procedures are preferred in uniformity with the classic methods of AIS treatment, owing to their effectiveness for clots in removal and less time-consuming recovery.
The use of thrombolytic agents including tPA remains on the increase in managing AIS cases. These medications disintegrate the blood clots allowing the delivery of blood to the brain, which has outstanding effects on the patients. More specifically, the pharmacological treatment of AIS benefits from new formulations allowing better control of active substances and from the development of more specific therapies.
Ongoing Research and Development
The AIS treatment market brings potentially attractive opportunities for the growth in such areas as Asia Pacific and Latin America. These two regions are emerging markets for AIS therapies because of the improved health care and boost in awareness of people regarding stroke and its prevention and treatment. Lifestyle-related diseases and ageing populations on the rise in these areas add to the need for better treatments.
High levels of R&D on the newer and better ways of treating different ailments provide a great chance of growth in the AIS market. Investigations into more specialized and efficient thrombectomy technologies, the newly developed thrombolytic agents and neuroprotective compounds may be considered fulfilling the imperative of discovering novel ways to enhance patient prognosis and diminish mortality.
Acute Ischemic Stroke (AIS) Market Segment Analysis:
Acute Ischemic Stroke (AIS) Market is Segmented on the basis of Product Type, Treatment Type, Application, and Region.
By Product Type, Medications segment is expected to dominate the market during the forecast period
The AIS market can be divided into medication and surgical devices. Each medication can be either an antithrombotic, thrombolytic or an anticoagulant; these are very important in dissolving clots and inhibiting their formation. Interventions that involve the use of instruments include; stent retrievers, and aspiration catheters that are used in procedures like thrombectomy in which devices are used to physically remove the clot or restore blood flow to the affected area in the brain. These two types of products both have their well-coordinated roles in management of AIS as the focus is now on integration of pharmacological management with newer surgical procedures.
By Treatment Type, Endovascular Therapy segment expected to held the largest share
Acute Ischemic Stroke treatment is primarily divided into two types: endovascular therapy and thrombolysis, it seems that training of clinicians and the use of modern equipment will play an important role. Common endovascular treatment includes thrombectomy, in this, an invasive operation is done using a narrow flexible tube inserted through vessels to take out a clot obstructing blood passage. Thrombolysis, on the other hand, consists in the giving of clot dissolving agents, such as tissue plasminogen activator (tPA) to help bring blood flow back to the brain. Both treatments are widely used in the management of AIS, and the selection depends on such parameters as time from onset of symptoms, and general condition of the patient.
Acute Ischemic Stroke (AIS) Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
North America AIS market holds the largest global market share due to the developed healthcare sector, higher healthcare expenditure, early aging population leading to higher need for AIS treatment. This is due to the high risking factors like hypertension, diabetics, and lifestyle diseases among the population thus requiring efficient manage of strokes. Also, the region experiences rapid technology acquisition including thrombectomy devices and thrombolytic agents that increase treatment choices, and the quality of the results.
Decisive government efforts, focused on effective primary and secondary prevention of strokes combined with raising public awareness for AIS have also played their part in enhanced management of AIS risks in North America. The fact that main market participants and constant research on novel treatment approaches, including individual medications and neuroprotectants, exist also contributes to market expansion. The United States and other countries in North American are expected to continue their dominance in the AIS market due to the development of both pharmacological and surgical techniques.
Active Key Players in the Acute Ischemic Stroke (AIS) Market
Abbott Laboratories (USA)
Boston Scientific Corporation (USA)
Hoya Corporation (Japan)
Johnson & Johnson (USA)
Medtronic (Ireland)
NeuroInterventional Care, Inc. (USA)
Penumbra Inc. (USA)
Siemens Healthineers (Germany)
Stryker Corporation (USA)
Terumo Corporation (Japan)
Other Active Players.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter’s Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Acute Ischemic Stroke (AIS) Market by product type
4.1 Acute Ischemic Stroke (AIS) Market Snapshot and Growth Engine
4.2 Acute Ischemic Stroke (AIS) Market Overview
4.3 medications
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 medications: Geographic Segmentation Analysis
4.4 surgical devicesTreatment
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 surgical devicesTreatment: Geographic Segmentation Analysis
Chapter 5: Acute Ischemic Stroke (AIS) Market by application
5.1 Acute Ischemic Stroke (AIS) Market Snapshot and Growth Engine
5.2 Acute Ischemic Stroke (AIS) Market Overview
5.3 hospitals
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 hospitals: Geographic Segmentation Analysis
5.4 specialty clinics
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 specialty clinics: Geographic Segmentation Analysis
5.5 ambulatory surgical centers
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 ambulatory surgical centers: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Acute Ischemic Stroke (AIS) Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 MEDTRONIC (IRELAND)
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 STRYKER CORPORATION (USA)
6.4 ABBOTT LABORATORIES (USA)
6.5 PENUMBRA INC. (USA)
6.6 JOHNSON & JOHNSON (USA)
6.7 BOSTON SCIENTIFIC CORPORATION (USA)
6.8 TERUMO CORPORATION (JAPAN)
6.9 SIEMENS HEALTHINEERS (GERMANY)
6.10 HOYA CORPORATION (JAPAN)
6.11 NEUROINTERVENTIONAL CARE INC. (USA)
6.12 OTHER ACTIVE PLAYERS
Chapter 7: Global Acute Ischemic Stroke (AIS) Market By Region
7.1 Overview
7.2. North America Acute Ischemic Stroke (AIS) Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By product type
7.2.4.1 medications
7.2.4.2 surgical devicesTreatment
7.2.5 Historic and Forecasted Market Size By application
7.2.5.1 hospitals
7.2.5.2 specialty clinics
7.2.5.3 ambulatory surgical centers
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Acute Ischemic Stroke (AIS) Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By product type
7.3.4.1 medications
7.3.4.2 surgical devicesTreatment
7.3.5 Historic and Forecasted Market Size By application
7.3.5.1 hospitals
7.3.5.2 specialty clinics
7.3.5.3 ambulatory surgical centers
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Russia
7.3.6.2 Bulgaria
7.3.6.3 The Czech Republic
7.3.6.4 Hungary
7.3.6.5 Poland
7.3.6.6 Romania
7.3.6.7 Rest of Eastern Europe
7.4. Western Europe Acute Ischemic Stroke (AIS) Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By product type
7.4.4.1 medications
7.4.4.2 surgical devicesTreatment
7.4.5 Historic and Forecasted Market Size By application
7.4.5.1 hospitals
7.4.5.2 specialty clinics
7.4.5.3 ambulatory surgical centers
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 The Netherlands
7.4.6.5 Italy
7.4.6.6 Spain
7.4.6.7 Rest of Western Europe
7.5. Asia Pacific Acute Ischemic Stroke (AIS) Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By product type
7.5.4.1 medications
7.5.4.2 surgical devicesTreatment
7.5.5 Historic and Forecasted Market Size By application
7.5.5.1 hospitals
7.5.5.2 specialty clinics
7.5.5.3 ambulatory surgical centers
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Acute Ischemic Stroke (AIS) Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By product type
7.6.4.1 medications
7.6.4.2 surgical devicesTreatment
7.6.5 Historic and Forecasted Market Size By application
7.6.5.1 hospitals
7.6.5.2 specialty clinics
7.6.5.3 ambulatory surgical centers
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkiye
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Acute Ischemic Stroke (AIS) Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By product type
7.7.4.1 medications
7.7.4.2 surgical devicesTreatment
7.7.5 Historic and Forecasted Market Size By application
7.7.5.1 hospitals
7.7.5.2 specialty clinics
7.7.5.3 ambulatory surgical centers
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Q1: What would be the forecast period in the Acute Ischemic Stroke (AIS) Market research report?
A1: The forecast period in the Acute Ischemic Stroke (AIS) Market research report is 2024-2032.
Q2: Who are the key players in the Acute Ischemic Stroke (AIS) Market?
A2: Medtronic (Ireland), Stryker Corporation (USA), Abbott Laboratories (USA), Penumbra Inc. (USA), Johnson & Johnson (USA), Boston Scientific Corporation (USA), Terumo Corporation (Japan), Siemens Healthineers (Germany), Hoya Corporation (Japan), NeuroInterventional Care, Inc. (USA), and Other Active Players.
Q3: What are the segments of the Acute Ischemic Stroke (AIS) Market?
A3: The Acute Ischemic Stroke (AIS) Market is segmented into by product type (medications, surgical devices), treatment type (endovascular therapy, thrombolysis), application (hospitals, specialty clinics, ambulatory surgical centers). By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Russia, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
Q4: What is the Acute Ischemic Stroke (AIS) Market?
A4: AIS is a stroke that is characterized by restricted blood flow to the brain due to the blood clot blocking or narrowing of the blood vessels that supply blood to the brain. This is a medical hazard, a condition that must be attended to practically immediately in order to reduce the amount of damage that occurs to the brain. Ischaemic strokes make up the largest share of all stroke cases, and the treatment for AIS embraces medications, neurosurgery, and endovascular procedures targeting vessel recanalization and prevention of long-term neurologic deficits.
Q5: How big is the Acute Ischemic Stroke (AIS) Market?
A5: Acute Ischemic Stroke (AIS) Market Size Was Valued at USD 9.24 Billion in 2023, and is Projected to Reach USD 13.73 Billion by 2032, Growing at a CAGR of 4.50% From 2024-2032.
How to Buy a Report from eminsights.jp
On the product page, choose the license you want: Single-User License, Multi-User License or Enterprise License.
If you required report in your native language, then you can click on Translated Report button and fill out the form with report name and language you want, then our team will contact you as soon as possible.
Click the Buy Now button.
You will be redirected to the checkout page. Enter your company details and payment information.
Click Place Order to complete the purchase.
Confirmation: You’ll receive an order confirmation and our team will contact you shortly with your ordered report.
If you have any questions, fill out the contact form below or email us at bizdev@eminsights.net.
Thank you for choosing eminsights.jp!
